ChemoCentryx Inc
CCXI
Get informed when a big investor buys or sells
+ FollowMarket Cap$580.73M
Close$
$0.01
99.9% downside
Current Fair Value
99.9% downsideOvervalued by 99.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $580.73 Million |
|---|---|
| Enterprise Value | $580.72 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.01 |
| Beta | 0.03 |
| Outstanding Shares | 55,700,000 |
Return
| Return on Equity | -320.49% |
|---|---|
| Return on Assets | -308.14% |
| Return on Invested Capital | -303.10% |
Valuation & Multiples
| P/E Ratio | 1332.69 |
|---|---|
| PEG | -1329.35 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 49.37 |
| Enterprise Value to EBIT | -18.59 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 48.57%▲ 48.57% |
|---|---|
| Total Invested | $274.93M |
| Investors Holding | 48▲ 48.00% |
ESG Score
No data
About ChemoCentryx Inc
CEO: Thomas Schall